nuMoM2b, which began in 2010, studies pregnant women who will be delivering for the first time (nulliparous women). This prospective cohort study evaluates the underlying, interrelated mechanisms of several common adverse pregnancy outcomes, which can be unpredictable in women who have little or no pregnancy history, to help guide their treatment. This initiative addresses a critical group of at-risk women who are currently understudied and represent 40% of U.S. births each year. The results of this study will help inform healthcare providers and their patients who are pregnant or considering pregnancy and will support future research to improve care and outcomes in this group of women.
The study was initiated by NICHD’s Pregnancy and Perinatology Branch and is primarily funded by NICHD, with co-funding from the NIH Office of Research on Women’s Health. A National Heart, Lung, and Blood Institute-funded substudy of 3,600 nuMoM2b participants is examining the relationship between sleep disorders during pregnancy and adverse pregnancy outcomes.
nuMoM2b is enrolling racially, ethnically, and geographically diverse pregnant women through 8 clinical research sites and 12 subsites around the country. These women participate in a variety of tests to identify potential mechanisms of adverse outcomes and predictive factors for the outcomes at four points during pregnancy.
Researchers may collect additional data through ancillary studies on subsets of the enrolled women.
nuMoM2b studies the mechanisms and prediction of adverse outcomes in pregnancy. The primary outcomes of interest are preterm birth, preeclampsia, fetal growth restriction, and stillbirth. The study aims to:
- Determine maternal characteristics and biomarkers, including genetics, epigenetics, and physiological response to pregnancy, as well as the environmental factors that can influence or predict adverse pregnancy outcomes
- Identify specific aspects of placental development and function that lead to adverse pregnancy outcomes
- Characterize genetic, growth, and developmental parameters of the fetus associated with adverse pregnancy outcomes
- Case Western Reserve University
- Columbia University
- Indiana University
- Northwestern University
- Magee-Women’s Hospital
- RTI International (data coordinating and analysis center)
- University of California, Irvine
- University of Pennsylvania
- University of Utah
In addition, 12 subsites are participating in nuMoM2b.
Decoding Maternal Morbidity Data Challenge (on Challenge.gov). NICHD invites innovative approaches to analyzing the nuMoM2b dataset for up to $400,000 in prizes. Winning submissions will identify new research avenues on adverse outcomes, such as hypertensive disorders, diabetes, and infection, and address disparities in these outcomes. Solutions can use computational analysis, data mining, artificial intelligence, and other methods to advance research in maternal health. Submissions are due by 10/15/21.